% Expired Patents = 14.3

Forward Citations = 1,212

Loading Chart...

10 inventors (with patents filed for the assignee):

Mark L Bonyhadi (3 out of 13 patents)

Dale Kalamasz (3 out of 9 patents)

Che Law (3 out of 5 patents)

4. Stewart Craig (3 out of 5 patents)

5. Alan Hardwick (3 out of 5 patents)

6. David McMillen (3 out of 5 patents)

7. Narinder Saund (3 out of 4 patents)

8. Søren Skov (3 out of 3 patents)

9. Ronald Jay Berenson (3 out of 26 patents)

10. Søren Skov (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 7041639 - Depsipeptide and congeners thereof for use as immunosuppressants (2006-05-09),

2. 6905874 - Simultaneous stimulation and concentration of cells (2005-06-14),

3. 6867041 - Simultaneous stimulation and concentration of cells (2005-03-15),

4. 6828302 - Therapeutic uses of depsipeptides and congeners thereof (2004-12-07),

5. 6797514 - Simultaneous stimulation and concentration of cells (2004-09-28),

6. 6548479 - Therapeutic uses of depsipeptides and congeners thereof (2003-04-15),

7. 6403555 - Depsipeptide and congeners thereof for use as immunosuppressants (2002-06-11),

Company Overview

Xcyte Therapies, Inc. is a biotechnology company focused on developing cutting-edge immunotherapies for the treatment of cancer and other diseases. Our innovative approach harnesses the power of the immune system to target and destroy cancer cells, offering new hope to patients facing difficult diagnoses. With a talented team of scientists and researchers, Xcyte Therapies is committed to advancing the field of immunotherapy and improving outcomes for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#272 in Seattle, WA

#927 in Washington

#39,907 in US

Seattle, WA, United States of America

Xcyte Therapies, Inc.

Forward Citations = 1,212

10 inventors:

Mark L Bonyhadi (3 out of 13 patents)

Dale Kalamasz (3 out of 9 patents)

Che Law (3 out of 5 patents)

4. Stewart Craig (3 out of 5 patents)

5. Alan Hardwick (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xcyte Therapies, Inc.. Retrieved from https://idiyas.com/company/xcyte-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]